GRIN2D (O15399) variants and mutations
GRIN2D (also known as O15399) is a human protein-coding gene encoding a glutamate receptor ionotropic, NMDA 2D protein. The GluN2D subunit of NMDA glutamate receptors, calcium-permeable channels involved in excitatory synaptic signaling. Variants can cause developmental and epileptic encephalopathy. This analysis covers 2,005 GRIN2D variants and mutations. Of these, 98% have computational variant effect predictions. Disease context includes developmental and epileptic encephalopathy, 46, Alzheimer disease, and Parkinson disease. Example GRIN2D variants include M1I, R2S, and R2G.
Variant analysis overview
- Gene: GRIN2D
- Protein: O15399
- UniProt accession: O15399
- Organism: Homo sapiens
- Variants analyzed: 2005
- Variant scope: all variants
- Completed: 2026-10-09
Variant and mutation evidence
- Variant composition: 1,593 unspecified-consequence records; 345 missense variants; 121 synonymous variants; 33 frameshift variants; 9 in-frame deletions; 2 in-frame insertions; 11 stop-gained variants; 2 substitution
- Prediction scores: 1,966 variants have prediction scores (98% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: developmental and epileptic encephalopathy, 46, Alzheimer disease, Parkinson disease, major depressive disorder, Orthomyxoviridae infectious disease, infection, depressive disorder, alcohol dependence, dementia, secondary Parkinson disease, cerebral atherosclerosis, postencephalitic Parkinson disease.
Protein structure and variant hotspots
- Protein features: 3 transmembrane segments; 6 binding sites; 8 post-translational modification sites.
- Structural context: 47 variants have structural context.
- PTM context: 11 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, ClinGen, MaveDB, LitVar.
Diseases linked to GRIN2D
Notable GRIN2D variants
Examples include M1I, R2S, R2G, R2C, R2H, R2L, R2R, G3R. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- M1I (p.Met1Ile), rs1970668133, ClinGen CA406688087, ClinVar RCV001757205, ESM-1b 1.00, AlphaMissense 0.52, Uncertain significance, not provided
- R2S (p.Arg2Ser), rs982702259, ClinGen CA309325405, ClinVar RCV003340845, ClinVar RCV003708774, REVEL 0.07, ESM-1b 0.00, Uncertain significance, not provided; Developmental and epileptic encephalopathy, 46
- R2G (p.Arg2Gly), gnomAD 19-48398396-C-G, REVEL 0.10, ESM-1b 0.00
- R2C (p.Arg2Cys), gnomAD 19-48398396-C-T, REVEL 0.04, ESM-1b 0.14
- R2H (p.Arg2His), gnomAD 19-48398397-G-A, REVEL 0.09, ESM-1b 1.00
- R2L (p.Arg2Leu), gnomAD 19-48398397-G-T, REVEL 0.09, ESM-1b 0.00
- R2R (p.Arg2Arg), gnomAD 19-48398398-C-G, CADD 15.60
- G3R (p.Gly3Arg), 1000Genomes rs908012919, TOPMed rs908012919, gnomAD rs908012919, REVEL 0.18, ESM-1b 0.00, Uncertain significance
- G3S (p.Gly3Ser), rs908012919, ClinGen CA309325415, ClinVar RCV002027054, ClinVar RCV006372565, REVEL 0.14, ESM-1b 0.00, Uncertain significance, Inborn genetic diseases; not provided
- G3C (p.Gly3Cys), gnomAD 19-48398399-G-T, REVEL 0.15, ESM-1b 0.39
- G3D (p.Gly3Asp), gnomAD 19-48398400-G-A, REVEL 0.31, ESM-1b 0.61
- G3V (p.Gly3Val), gnomAD 19-48398400-G-T, REVEL 0.19, ESM-1b 0.00
- G3G (p.Gly3Gly), rs2147434047, gnomAD 19-48398401-C-T, CADD 13.90
- A4S (p.Ala4Ser), gnomAD 19-48398402-G-T, REVEL 0.02, ESM-1b 0.00
- A4P (p.Ala4Pro), gnomAD 19-48398402-G-C, REVEL 0.02, ESM-1b 0.00
- A4T (p.Ala4Thr), gnomAD 19-48398402-G-A, REVEL 0.03, ESM-1b 0.00
- A4G (p.Ala4Gly), gnomAD 19-48398403-C-G, REVEL 0.04, ESM-1b 0.00
- A4V (p.Ala4Val), gnomAD 19-48398403-C-T, REVEL 0.03, ESM-1b 0.12
- A4D (p.Ala4Asp), gnomAD 19-48398403-C-A, REVEL 0.04, ESM-1b 0.61
- A4A (p.Ala4Ala), rs961422663, gnomAD 19-48398404-C-T, CADD 15.30
- G5C (p.Gly5Cys), rs2147434057, ClinGen CA406688106, ClinVar RCV001981465, Ensembl rs2147434057, REVEL 0.16, ESM-1b 0.15, Uncertain significance, not provided
- G5S (p.Gly5Ser), rs2147434057, ClinGen CA406688104, ClinVar RCV003579796, REVEL 0.11, ESM-1b 0.00, Uncertain significance, not provided
- G5V (p.Gly5Val), TOPMed rs1970668308, REVEL 0.13, ESM-1b 0.00
- G5R (p.Gly5Arg), gnomAD 19-48398405-G-C, REVEL 0.12, ESM-1b 0.00
- G5D (p.Gly5Asp), gnomAD 19-48398406-G-A, REVEL 0.15, ESM-1b 1.00
- G5G (p.Gly5Gly), gnomAD 19-48398407-T-C, CADD 15.70
- G6A (p.Gly6Ala), gnomAD 19-48398407-TG-T, CADD 28.00
- G6C (p.Gly6Cys), gnomAD 19-48398408-G-T, REVEL 0.16, ESM-1b 0.68
- G6S (p.Gly6Ser), gnomAD 19-48398408-G-A, REVEL 0.08, ESM-1b 0.00
- G6V (p.Gly6Val), gnomAD 19-48398409-G-T, REVEL 0.11, ESM-1b 0.25
- G6D (p.Gly6Asp), gnomAD 19-48398409-G-A, REVEL 0.13, ESM-1b 0.66
- G6G (p.Gly6Gly), gnomAD 19-48398410-C-A, CADD 14.90
- P7L (p.Pro7Leu), TOPMed rs1420512505, REVEL 0.04, ESM-1b 0.00
- P7S (p.Pro7Ser), gnomAD 19-48398411-C-T, REVEL 0.07, ESM-1b 0.00
- P7T (p.Pro7Thr), gnomAD 19-48398411-C-A, REVEL 0.08, ESM-1b 0.00
- P7A (p.Pro7Ala), gnomAD 19-48398411-C-G, REVEL 0.10, ESM-1b 0.00
- P7H (p.Pro7His), gnomAD 19-48398412-C-A, REVEL 0.10, ESM-1b 0.64
- P7R (p.Pro7Arg), gnomAD 19-48398412-C-G, REVEL 0.12, ESM-1b 0.00
- P7P (p.Pro7Pro), gnomAD 19-48398413-C-A, CADD 15.30
- R8H (p.Arg8His), Ensembl rs1970668423, REVEL 0.08, ESM-1b 0.76
- R8S (p.Arg8Ser), rs2147434074, ClinGen CA406688122, ClinVar RCV003031036, 1000Genomes rs2147434074, REVEL 0.05, ESM-1b 0.00, Uncertain significance, not provided
- R8L (p.Arg8Leu), gnomAD 19-48398409-GCCCC, CADD 31.00
- R8P (p.Arg8Pro), gnomAD 19-48398409-G-GC, CADD 28.90
- R8A (p.Arg8Ala), gnomAD 19-48398409-GC-G, CADD 25.80
- R8C (p.Arg8Cys), gnomAD 19-48398414-C-T, REVEL 0.06, ESM-1b 0.07
- R8R (p.Arg8Arg), gnomAD 19-48398416-C-G, CADD 15.80
- G9D (p.Gly9Asp), TOPMed rs972423258, REVEL 0.10, ESM-1b 0.68
- G9S (p.Gly9Ser), rs2516061557, ClinGen CA406688128, ClinVar RCV002792079, REVEL 0.07, ESM-1b 0.00, Uncertain significance, not provided
- G9A (p.Gly9Ala), gnomAD 19-48398415-GC-G, CADD 26.50
- G9C (p.Gly9Cys), gnomAD 19-48398417-G-T, REVEL 0.10, ESM-1b 0.37
- G9V (p.Gly9Val), gnomAD 19-48398418-G-T, REVEL 0.10, ESM-1b 0.03
- G9G (p.Gly9Gly), gnomAD 19-48398419-C-T, CADD 15.60
- P10L (p.Pro10Leu), rs2516061577, ClinGen CA406688138, ClinVar RCV004395892, REVEL 0.06, ESM-1b 0.00, Uncertain significance, Inborn genetic diseases
- P10T (p.Pro10Thr), TOPMed rs1473663651, gnomAD rs1473663651, REVEL 0.06, ESM-1b 0.00, Uncertain significance, Inborn genetic diseases; not provided
- P10A (p.Pro10Ala), gnomAD 19-48398420-C-G, REVEL 0.10, ESM-1b 0.00
- P10S (p.Pro10Ser), gnomAD 19-48398420-C-T, REVEL 0.05, ESM-1b 0.00
- P10R (p.Pro10Arg), gnomAD 19-48398421-C-G, REVEL 0.10, ESM-1b 0.00
- P10H (p.Pro10His), gnomAD 19-48398421-C-A, REVEL 0.11, ESM-1b 0.62
- P10P (p.Pro10Pro), rs1368935415, gnomAD 19-48398422-T-C, CADD 17.00
- R11W (p.Arg11Trp), TOPMed rs1970668628, REVEL 0.08, ESM-1b 0.00, Uncertain significance, not provided
- p.Arg11 Pro13del, rs1360207254, gnomAD 19-48398416-CGGCC, CADD 21.10
- R11R (p.Arg11Arg), gnomAD 19-48398423-C-A, CADD 15.90
- R11Q (p.Arg11Gln), gnomAD 19-48398424-G-A, REVEL 0.06, ESM-1b 0.05
- R11L (p.Arg11Leu), gnomAD 19-48398424-G-T, REVEL 0.04, ESM-1b 0.00
- G12D (p.Gly12Asp), Ensembl rs1970668701, REVEL 0.13, ESM-1b 0.59
- G12S (p.Gly12Ser), rs1970668670, ClinGen CA406688144, ClinVar RCV003662297, ClinVar RCV004621840, REVEL 0.06, ESM-1b 0.00, Uncertain significance, not provided; Inborn genetic diseases
- G12V (p.Gly12Val), Ensembl rs1970668701, REVEL 0.11, ESM-1b 0.00
- G12A (p.Gly12Ala), gnomAD 19-48398423-CG-C, CADD 25.70
- G12C (p.Gly12Cys), gnomAD 19-48398426-G-T, REVEL 0.11, ESM-1b 0.00
- G12G (p.Gly12Gly), gnomAD 19-48398428-C-T, CADD 15.30
- P13S (p.Pro13Ser), gnomAD 19-48398429-C-T, REVEL 0.07, ESM-1b 0.00
- P13T (p.Pro13Thr), gnomAD 19-48398429-C-A, REVEL 0.10, ESM-1b 0.00
- P13A (p.Pro13Ala), gnomAD 19-48398429-C-G, REVEL 0.07, ESM-1b 0.00
- P13L (p.Pro13Leu), gnomAD 19-48398430-C-T, REVEL 0.13, ESM-1b 0.00
- P13H (p.Pro13His), gnomAD 19-48398430-C-A, REVEL 0.07, ESM-1b 0.85
- P13P (p.Pro13Pro), rs1970668743, gnomAD 19-48398431-C-A, CADD 15.60
- A14L (p.Ala14Leu), gnomAD 19-48398427-GC-G, CADD 25.30
- A14P (p.Ala14Pro), gnomAD 19-48398432-G-C, REVEL 0.11, ESM-1b 0.00
- A14S (p.Ala14Ser), gnomAD 19-48398432-G-T, REVEL 0.07, ESM-1b 0.00
- A14T (p.Ala14Thr), gnomAD 19-48398432-G-A, REVEL 0.11, ESM-1b 0.00
- A14D (p.Ala14Asp), gnomAD 19-48398433-C-A, REVEL 0.13, ESM-1b 1.00
- A14V (p.Ala14Val), gnomAD 19-48398433-C-T, REVEL 0.10, ESM-1b 0.00
- A14A (p.Ala14Ala), gnomAD 19-48398434-T-C, CADD 17.00
- K15R (p.Lys15Arg), gnomAD 19-48398434-TA-T, CADD 28.20
- K15E (p.Lys15Glu), gnomAD 19-48398435-A-G, REVEL 0.04, ESM-1b 0.00
- K15M (p.Lys15Met), gnomAD 19-48398436-A-T, REVEL 0.09, ESM-1b 0.00
- K15K (p.Lys15Lys), gnomAD 19-48398437-G-A, CADD 14.00
- K15N (p.Lys15Asn), gnomAD 19-48398437-G-C, REVEL 0.07, ESM-1b 0.00
- M16L (p.Met16Leu), gnomAD 19-48398438-A-T, REVEL 0.07, ESM-1b 0.00
- M16V (p.Met16Val), gnomAD 19-48398438-A-G, REVEL 0.11, ESM-1b 0.00
- M16K (p.Met16Lys), gnomAD 19-48398439-T-A, REVEL 0.16, ESM-1b 0.00
- M16T (p.Met16Thr), gnomAD 19-48398439-T-C, REVEL 0.12, ESM-1b 0.00
- M16I (p.Met16Ile), gnomAD 19-48398440-G-T, REVEL 0.09, ESM-1b 0.00
- L17M (p.Leu17Met), gnomAD 19-48398441-C-A, REVEL 0.04, ESM-1b 1.00
- L17L (p.Leu17Leu), gnomAD 19-48398441-C-T, CADD 14.10
- L17V (p.Leu17Val), gnomAD 19-48398441-C-G, REVEL 0.04, ESM-1b 0.10
- L17P (p.Leu17Pro), gnomAD 19-48398442-T-C, REVEL 0.21, ESM-1b 0.29
- L17Q (p.Leu17Gln), gnomAD 19-48398442-T-A, REVEL 0.14, ESM-1b 1.00
- L18A (p.Leu18Ala), gnomAD 19-48398443-GCT-G, CADD 26.30
- L18V (p.Leu18Val), gnomAD 19-48398444-C-G, REVEL 0.04, ESM-1b 0.00
- L18M (p.Leu18Met), gnomAD 19-48398444-C-A, REVEL 0.04, ESM-1b 1.00
- L18L (p.Leu18Leu), gnomAD 19-48398444-C-T, CADD 14.00
- L18P (p.Leu18Pro), gnomAD 19-48398445-T-C, REVEL 0.23, ESM-1b 0.12
- L19L (p.Leu19Leu), gnomAD 19-48398447-C-T, CADD 13.50
- L19M (p.Leu19Met), gnomAD 19-48398447-C-A, REVEL 0.06, ESM-1b 1.00
- L19P (p.Leu19Pro), gnomAD 19-48398448-T-C, REVEL 0.20, ESM-1b 0.36
- L20V (p.Leu20Val), TOPMed rs1264683401, gnomAD rs1264683401, REVEL 0.04, ESM-1b 0.00
- L20del (p.Leu20del), rs919633142, gnomAD 19-48398438-ATGC-, CADD 21.20
- p.Leu20dup, rs919633142, gnomAD 19-48398438-A-ATG, CADD 20.30
- L20W (p.Leu20Trp), gnomAD 19-48398448-TG-T, CADD 22.40
- L20M (p.Leu20Met), gnomAD 19-48398450-C-A, REVEL 0.04, ESM-1b 1.00
- L20L (p.Leu20Leu), gnomAD 19-48398450-C-T, CADD 13.70
- L20P (p.Leu20Pro), gnomAD 19-48398451-T-C, REVEL 0.21, ESM-1b 0.51
- A21V (p.Ala21Val), gnomAD rs1293786564, REVEL 0.07, ESM-1b 0.00
- A21R (p.Ala21Arg), gnomAD 19-48398451-TG-T, CADD 25.50
- A21S (p.Ala21Ser), gnomAD 19-48398453-G-T, REVEL 0.09, ESM-1b 0.00
- A21T (p.Ala21Thr), gnomAD 19-48398453-G-A, REVEL 0.08, ESM-1b 0.00
- A21G (p.Ala21Gly), gnomAD 19-48398454-C-G, REVEL 0.05, ESM-1b 0.00
- A21E (p.Ala21Glu), gnomAD 19-48398454-C-A, REVEL 0.14, ESM-1b 1.00
- A21A (p.Ala21Ala), gnomAD 19-48398455-G-T, CADD 14.30
- L22Q (p.Leu22Gln), rs1600967281, ClinGen CA406688208, ClinVar RCV003929731, Ensembl rs1600967281, REVEL 0.13, ESM-1b 1.00, Likely benign, GRIN2D-related disorder
- p.Leu22 Ala23del, gnomAD 19-48398448-TGCTG, CADD 19.60
- L22P (p.Leu22Pro), gnomAD 19-48398456-CTGGC, CADD 25.80
- L22M (p.Leu22Met), gnomAD 19-48398456-C-A, REVEL 0.06, ESM-1b 1.00
- L22L (p.Leu22Leu), gnomAD 19-48398456-C-T, CADD 13.40
- L22R (p.Leu22Arg), gnomAD 19-48398457-T-G, REVEL 0.25, ESM-1b 0.29
- A23G (p.Ala23Gly), TOPMed rs1970669030, REVEL 0.06, ESM-1b 0.00, Uncertain significance, not provided
- A23T (p.Ala23Thr), TOPMed rs1970668991, gnomAD rs1970668991, REVEL 0.05, ESM-1b 0.00, Uncertain significance, Inborn genetic diseases
- p.Ala23 Leu45del, gnomAD 19-48398455-GCTGG, CADD 19.60
- A23P (p.Ala23Pro), gnomAD 19-48398457-TG-T, CADD 23.20
- A23S (p.Ala23Ser), gnomAD 19-48398459-G-T, REVEL 0.06, ESM-1b 0.00
- A23D (p.Ala23Asp), gnomAD 19-48398460-C-A, REVEL 0.14, ESM-1b 1.00
- A23V (p.Ala23Val), gnomAD 19-48398460-C-T, REVEL 0.04, ESM-1b 0.00
- A23A (p.Ala23Ala), rs1289811637, gnomAD 19-48398461-C-T, CADD 14.20
- C24S (p.Cys24Ser), rs1600967287, ClinGen CA406688218, ClinVar RCV003939333, Ensembl rs1600967287, REVEL 0.14, ESM-1b 0.00, Likely benign, GRIN2D-related disorder
- C24R (p.Cys24Arg), gnomAD 19-48398462-T-C, REVEL 0.17, ESM-1b 0.00
- C24G (p.Cys24Gly), gnomAD 19-48398462-T-G, REVEL 0.17, ESM-1b 0.00
- C24F (p.Cys24Phe), gnomAD 19-48398463-G-T, REVEL 0.10, ESM-1b 0.00
- C24Y (p.Cys24Tyr), gnomAD 19-48398463-G-A, REVEL 0.11, ESM-1b 0.12
- C24W (p.Cys24Trp), gnomAD 19-48398464-C-G, REVEL 0.14, ESM-1b 0.00
- C24* (p.Cys24Ter), gnomAD 19-48398464-C-A, CADD 33.00
- C24C (p.Cys24Cys), rs1366392407, gnomAD 19-48398464-C-T, CADD 13.50
- A25T (p.Ala25Thr), gnomAD 19-48398465-G-A, REVEL 0.12, ESM-1b 0.68
- A25P (p.Ala25Pro), gnomAD 19-48398465-G-C, REVEL 0.16, ESM-1b 0.00
- A25S (p.Ala25Ser), gnomAD 19-48398465-G-T, REVEL 0.15, ESM-1b 0.00
- A25D (p.Ala25Asp), gnomAD 19-48398466-C-A, REVEL 0.19, ESM-1b 1.00
- A25V (p.Ala25Val), gnomAD 19-48398466-C-T, REVEL 0.08, ESM-1b 0.00
- A25A (p.Ala25Ala), gnomAD 19-48398467-C-G, CADD 14.80
- S26R (p.Ser26Arg), gnomAD rs1384698150, REVEL 0.20, ESM-1b 0.00
- S26C (p.Ser26Cys), gnomAD 19-48398468-A-T, REVEL 0.08, ESM-1b 0.00
- S26G (p.Ser26Gly), gnomAD 19-48398468-A-G, REVEL 0.07, ESM-1b 0.00
- S26N (p.Ser26Asn), gnomAD 19-48398469-G-A, REVEL 0.05, ESM-1b 1.00
- S26T (p.Ser26Thr), gnomAD 19-48398469-G-C, REVEL 0.07, ESM-1b 0.00
- S26I (p.Ser26Ile), gnomAD 19-48398469-G-T, REVEL 0.14, ESM-1b 0.56
- S26S (p.Ser26Ser), gnomAD 19-48398470-C-T, CADD 15.00
- P27Q (p.Pro27Gln), Ensembl rs1970669217, REVEL 0.08, ESM-1b 0.00
- P27A (p.Pro27Ala), gnomAD 19-48398471-C-G, REVEL 0.04, ESM-1b 0.00
- P27S (p.Pro27Ser), gnomAD 19-48398471-C-T, REVEL 0.05, ESM-1b 0.00
- P27T (p.Pro27Thr), gnomAD 19-48398471-C-A, REVEL 0.07, ESM-1b 0.00
- P27L (p.Pro27Leu), gnomAD 19-48398472-C-T, REVEL 0.09, ESM-1b 0.00
- P27P (p.Pro27Pro), rs1308597718, gnomAD 19-48398473-G-T, CADD 13.50
- F28L (p.Phe28Leu), TOPMed rs1970669308, REVEL 0.10, ESM-1b 0.00, Uncertain significance, not provided
- F28V (p.Phe28Val), gnomAD 19-48398474-T-G, REVEL 0.16, ESM-1b 0.00
- F28S (p.Phe28Ser), gnomAD 19-48398475-T-C, REVEL 0.18, ESM-1b 0.00
- F28F (p.Phe28Phe), gnomAD 19-48398476-C-T, CADD 15.20
- P29Q (p.Pro29Gln), gnomAD rs1350529318, REVEL 0.08, ESM-1b 0.00
- P29R (p.Pro29Arg), gnomAD 19-48398475-TC-T, CADD 26.30
- P29T (p.Pro29Thr), gnomAD 19-48398477-C-A, REVEL 0.07, ESM-1b 0.00
- P29S (p.Pro29Ser), gnomAD 19-48398477-C-T, REVEL 0.06, ESM-1b 0.00
- P29L (p.Pro29Leu), gnomAD 19-48398478-C-T, REVEL 0.04, ESM-1b 0.00
- P29P (p.Pro29Pro), gnomAD 19-48398479-G-T, CADD 14.70
- E30K (p.Glu30Lys), rs1970669406, ClinGen CA406688258, ClinVar RCV001252261, ClinVar RCV001879846, REVEL 0.14, ESM-1b 0.00, Uncertain significance, not provided
- E30Q (p.Glu30Gln), Ensembl rs1970669406, REVEL 0.08, ESM-1b 0.00, Uncertain significance, not provided
- E30G (p.Glu30Gly), gnomAD 19-48398478-CGG-C, CADD 26.60
- E30* (p.Glu30Ter), gnomAD 19-48398480-G-T, CADD 36.00
- E30D (p.Glu30Asp), gnomAD 19-48398482-G-T, REVEL 0.07, ESM-1b 0.00
- E30E (p.Glu30Glu), gnomAD 19-48398482-G-A, CADD 12.50
- E31Q (p.Glu31Gln), gnomAD 19-48398483-G-C, REVEL 0.08, ESM-1b 0.00
- E31K (p.Glu31Lys), gnomAD 19-48398483-G-A, REVEL 0.13, ESM-1b 0.03
- E31* (p.Glu31Ter), gnomAD 19-48398483-G-T, CADD 35.00
Public GRIN2D analysis runs
- GRIN2D analysis run — GRIN2D (2,005 variants) — completed 2026-10-09